Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases

SMi Group

Press Release

Receive press releases from SMi Group: By Email RSS Feeds:

Registration Now Live for SMiís 12th Annual Asthma & COPD Conference and Exhibition

SMi Group Reports (26.11.2015): Its 12th annual conference on Asthma & COPD will be held in London on the 11th - 12th April 2016.

London, United Kingdom, November 28, 2015 --( Respiratory diseases represent an enormous and increasing healthcare and economic burden across Europe and USA.

Over the last few years, significant improvements in the management of asthma and COPD have been made, owing to new drugs, strategies and to the development of the nonpharmacologic treatment of COPD. Nevertheless, there are still many unmet needs in the treatment of these diseases.

The conference will explore innovative asthma and COPD drug development programmes, directives and procedures which have been put in place to reduce the enormous suffering from lung disease and its high mortality.

Keynote speakers for 2016 include:
• (Chairman) - Ewan Walters, Medical Director, Teva UK
• Peter Daley-Yates, Director Clinical Pharmacology, GSK
• Andy Kenwright, Senior Statistical Scientist, Roche Pharma
• Jan Olof Svensson, Principal Scientist, AstraZeneca
• Roland Kolbeck, Senior Director, MedImmune
• Nayna Govind, Director for the Development of Generic Inhalation Products, Dr. Reddy's Laboratories
• Konstantinos Kostikas, Medical Director Respiratory, Novartis

For more information, to review the full agenda or to register please visit the event website at

Highlights of Asthma & COPD 2016 include:
• Discuss the challenges for generic inhalation products for EU and US markets
• Gain insight into scientific aspects of quality regulations in respiratory drug development
• Review innate lymphocytes (ILC) in COPD
• Learn about "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
• Explore corticosteroid insensitivity in severe asthma
• Study formulation and process of inhaled products
• Analyse clinical development of generic

In addition to the conference, the event will feature 2 interactive half-day post-conference workshops held on the 13th April 2016.
1. Human factors and inhaler handling studies
Workshop Leader: Stefan Leiner, Chemical - Pharmaceutical Expert, Boehringer Ingelheim
2. Pragmatic compliance remediation - how to get your marketed product into shape?
Workshop Leader: Mark Chipperfield, Principal Consultant, Corvus Device Limited

For more information or to register visit the event website at

To take advantage of the EARLY BIRD OFFER register before the 18th December 2015 to save £400 off the conference price.

For delegate enquiries contact Matthew Apps +44 (0) 20 7827 6093 or email

For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email:

For media enquiries contact Anna Serazetdinova on +44 (0) 20 7827 6180 or email

12th annual Asthma & COPD conference and exhibition
11th – 12th April 2016
London, UK
Contact e-mail:
Contact number: +44 (0) 20 7827 6093
Event Website:
Contact Information
SMi Group
Anna Serazetdinova
+44 (0) 20 7827 6093

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business